IN2012DN06631A - - Google Patents
Info
- Publication number
- IN2012DN06631A IN2012DN06631A IN6631DEN2012A IN2012DN06631A IN 2012DN06631 A IN2012DN06631 A IN 2012DN06631A IN 6631DEN2012 A IN6631DEN2012 A IN 6631DEN2012A IN 2012DN06631 A IN2012DN06631 A IN 2012DN06631A
- Authority
- IN
- India
- Prior art keywords
- yloxy
- methyl
- isoxazol
- pyran
- piperidin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30492110P | 2010-02-16 | 2010-02-16 | |
| PCT/IB2011/050548 WO2011101774A1 (en) | 2010-02-16 | 2011-02-09 | (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN06631A true IN2012DN06631A (fi) | 2015-10-23 |
Family
ID=43904611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN6631DEN2012 IN2012DN06631A (fi) | 2010-02-16 | 2011-02-09 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20120041026A1 (fi) |
| EP (1) | EP2536713A1 (fi) |
| JP (1) | JP2013519722A (fi) |
| KR (1) | KR20120123089A (fi) |
| CN (1) | CN102762554A (fi) |
| AR (1) | AR080172A1 (fi) |
| AU (1) | AU2011216950A1 (fi) |
| CA (1) | CA2788656A1 (fi) |
| IN (1) | IN2012DN06631A (fi) |
| MX (1) | MX2012008721A (fi) |
| SG (1) | SG183111A1 (fi) |
| TW (1) | TW201141856A (fi) |
| UY (1) | UY33225A (fi) |
| WO (1) | WO2011101774A1 (fi) |
| ZA (1) | ZA201206469B (fi) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| US10583138B2 (en) | 2012-07-12 | 2020-03-10 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| MX350024B (es) * | 2011-05-18 | 2017-08-23 | Raqualia Pharma Inc | Formas polimorfas del ácido 4-{[4-({[4-(2,2,2-trifluoroetoxi)-1,2- benzisoxazol-3-il]oxi}metil)piperidin-1-il]metil}-tetrahidro-2h-p iran-4-carboxílico. |
| ES2637539T3 (es) * | 2012-11-21 | 2017-10-13 | Raqualia Pharma Inc | Polimorfos de ácido 4-{[4-({[4-(2,2,2-trifluoroetoxi)-1,2-benzoisoxazol-3-il]oxi}metil)piperidin-1-il]metil}-tetrahidro-2H-piran-4-carboxílico como agonistas del receptor de 5-hidroxitriptamina-4 (5-HT4) para el tratamiento de enfermedades gastrointestinales |
| AP2015008742A0 (en) | 2013-03-20 | 2015-09-30 | Suven Life Sciences Ltd | 5-amino quinoline-8-carboxamide derivatives as 5-ht4 receptor agonists |
| MX368017B (es) | 2013-12-16 | 2019-09-13 | Suven Life Sciences Ltd | Compuestos de indazol como agonistas del receptor de 5-ht4. |
| MX366985B (es) * | 2014-05-20 | 2019-08-01 | Raqualia Pharma Inc | Sales derivadas de bencisoxazol. |
| AU2016217461B2 (en) | 2015-02-13 | 2018-07-05 | Suven Life Sciences Limited | Amide compounds as 5-HT4 receptor agonists |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992015565A1 (en) | 1991-02-27 | 1992-09-17 | Merrell Dow Pharmaceuticals Inc. | Nmda antagonists |
| US5750542A (en) * | 1993-09-28 | 1998-05-12 | Pfizer | Benzisoxazole and benzisothizole derivatives as cholinesterase inhibitors |
| NZ243065A (en) * | 1991-06-13 | 1995-07-26 | Lundbeck & Co As H | Piperidine derivatives and pharmaceutical compositions |
| JP3462501B2 (ja) * | 1992-11-23 | 2003-11-05 | アベンティス・ファーマスーティカルズ・インコーポレイテツド | 置換された３−（アミノアルキルアミノ）−１，２−ベンゾイソキサゾールおよび関連化合物 |
| US5889006A (en) | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
| IL117149A0 (en) | 1995-02-23 | 1996-06-18 | Schering Corp | Muscarinic antagonists |
| ATE221520T1 (de) | 1995-09-29 | 2002-08-15 | Glaxo Wellcome Spa | Tetrahydrochinoline als nmda antagonisten |
| IL126003A0 (en) | 1996-04-10 | 1999-04-11 | Hoechst Marion Roussel Inc | Spiro [cyclopent [b] indole-piperidines] and n-[phenyl-hydrazon intermediates for their preparation both being acetyl cholinesterase and mao inhibitors |
| IL126308A0 (en) | 1996-04-12 | 1999-05-09 | Hoechst Marion Roussel Inc | Isatin derivatives as acetylcholinesterase inhibitors and analgesics |
| IL127858A0 (en) | 1996-07-01 | 1999-10-28 | Schering Corp | Muscarinic antagonists |
| ES2241053T3 (es) | 1996-08-15 | 2005-10-16 | Schering Corporation | Eteres antagonistas muscarinicos. |
| HUP0000882A3 (en) | 1996-09-30 | 2001-04-28 | Aventis Pharmaceuticals Inc Br | Indole derivatives as nmda (n-methyl-d-aspartate) antagonists and pharmaceutical compositions containing them |
| CN1572299A (zh) | 1998-09-30 | 2005-02-02 | 武田药品工业株式会社 | 改善膀胱排泄能力的药物 |
| DE60223904T2 (de) | 2001-01-26 | 2008-11-27 | Btg International Ltd. | Benzylaminanalogen |
| EP1436258A4 (en) | 2001-03-08 | 2005-03-23 | Univ Emory | ANTAGONISTS OF THE NMDA RECEPTOR DEPENDENT OF PH |
| AU2002338334B8 (en) | 2001-04-03 | 2008-09-18 | Merck & Co., Inc. | N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B antagonists |
| EP1409477B1 (en) | 2001-07-24 | 2008-09-17 | Richter Gedeon NYRT | Piperidine derivatives as nmda receptor antagonists |
| WO2004108705A1 (en) | 2003-06-04 | 2004-12-16 | Merck & Co., Inc. | 3-fluoro-piperidines as nmda/nr2b antagonists |
| GB0316094D0 (en) | 2003-07-09 | 2003-08-13 | Neuropharma Sa | Acetylcholinesterase dual inhibitors |
| SG10201803560WA (en) * | 2004-03-03 | 2018-06-28 | Revance Therapeutics Inc | Compositions And Methods For Topical Application And Transdermal Delivery Of Botulinum Toxins |
| HU227119B1 (en) | 2004-07-29 | 2010-07-28 | Richter Gedeon Nyrt | Indole and benzimidazole carboxylic acid amide derivatives and pharmaceutical compositions containing them |
| HU226977B1 (en) | 2004-07-29 | 2010-04-28 | Richter Gedeon Nyrt | Kynurenic acid amide derivatives, pharmaceutical compositions containing them and process for producing them |
| HUP0401522A2 (en) | 2004-07-29 | 2006-04-28 | Richter Gedeon Vegyeszet | New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation |
| HUP0401523A3 (en) | 2004-07-29 | 2007-05-02 | Richter Gedeon Vegyeszet | Indole-2-carboxamide derivatives, pharmaceutical compositions containing them and process for producing them |
| HU227000B1 (en) | 2004-07-29 | 2010-04-28 | Richter Gedeon Nyrt | Nmda receptor antagonist benzoyl urea derivatives, and pharmaceutical compositions containing them |
| TW200621677A (en) | 2004-09-21 | 2006-07-01 | Astellas Pharma Inc | Cyclic amine derivative or salt thereof |
| US8273893B2 (en) | 2004-10-15 | 2012-09-25 | Viegas Jr Claudio | Piperidinic derivatives, pharmaceutic compositions containing the same and preparation processes |
| CA2598516C (en) * | 2005-02-25 | 2010-05-11 | Pfizer Inc. | Benzisoxazole derivatives |
| US20090124600A1 (en) | 2005-04-19 | 2009-05-14 | Layton Mark E | N-Alkyl-Azacycloalkyl NMDA/NR2B Antagonists |
| EP1915624A1 (en) | 2005-07-29 | 2008-04-30 | Regents of the University of Minnesota | Amyloid beta receptor and uses thereof |
| JP2009531323A (ja) | 2006-03-20 | 2009-09-03 | カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ | アセチルコリンエステラーゼ阻害剤として有用な薬剤組成物 |
| ES2288406B1 (es) | 2006-04-20 | 2008-12-16 | Universidad De Barcelona | Compuestos inhibidores de acetilcolinesterasa para el tratamiento de la enfermedad de alzheimer. |
| CA2672814A1 (en) | 2006-12-20 | 2008-06-26 | Solvay Pharmaceuticals B.V. | Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition |
| US7605265B2 (en) | 2007-01-22 | 2009-10-20 | Biotechnology Research Corporation Ltd. | Heterodimers and methods of using them |
| PL2522667T3 (pl) | 2007-05-01 | 2015-01-30 | Concert Pharmaceuticals Inc | Związki morfinanu |
| CN101730706B (zh) | 2007-05-11 | 2015-04-15 | 生物科技研究有限公司 | 具有神经保护和增强记忆活性的受体拮抗剂 |
| EP2170334B1 (en) | 2007-06-29 | 2021-03-17 | Emory University | Nmda receptor antagonists for neuroprotection |
| WO2009036235A2 (en) | 2007-09-12 | 2009-03-19 | Virginia Tech Intellectual Properties, Inc. | Insecticidal carbamates exhibiting species-selective inhibition of acetylcholinesterase (ache) |
| WO2009092324A1 (en) | 2008-01-16 | 2009-07-30 | Hong Kong University Of Science And Technology | Oxazolidine derivatives as nmda antagonists |
| EA014100B1 (ru) | 2008-02-21 | 2010-08-30 | Общество С Ограниченной Ответственностью "Валексфарм" | Производные 2,4-диаминопиридина, фармацевтическая композиция, лекарственное средство на их основе для лечения или предупреждения заболеваний и нарушений, вызванных гиперактивацией nmda-рецепторов и/или в качестве стимуляторов когнитивных функций и способ лечения |
| CN101440061B (zh) | 2008-04-08 | 2010-12-08 | 温州医学院 | 一类具有抑制乙酰胆碱酯酶活性的芳基吡啶酮类衍生物 |
| WO2009129181A1 (en) | 2008-04-14 | 2009-10-22 | Concert Pharmaceuticals Inc. | Propanediol-dicarbamate derivatives |
| SG195568A1 (en) | 2008-05-09 | 2013-12-30 | Univ Emory | Nmda receptor antagonists for the treatment of neuropsychiatric disorders |
-
2011
- 2011-02-09 CA CA2788656A patent/CA2788656A1/en not_active Abandoned
- 2011-02-09 MX MX2012008721A patent/MX2012008721A/es not_active Application Discontinuation
- 2011-02-09 KR KR1020127021310A patent/KR20120123089A/ko not_active Application Discontinuation
- 2011-02-09 JP JP2012553423A patent/JP2013519722A/ja not_active Withdrawn
- 2011-02-09 CN CN2011800099647A patent/CN102762554A/zh active Pending
- 2011-02-09 WO PCT/IB2011/050548 patent/WO2011101774A1/en active Application Filing
- 2011-02-09 SG SG2012053906A patent/SG183111A1/en unknown
- 2011-02-09 AU AU2011216950A patent/AU2011216950A1/en not_active Abandoned
- 2011-02-09 EP EP11710564A patent/EP2536713A1/en not_active Withdrawn
- 2011-02-09 IN IN6631DEN2012 patent/IN2012DN06631A/en unknown
- 2011-02-14 UY UY0001033225A patent/UY33225A/es not_active Application Discontinuation
- 2011-02-14 AR ARP110100443A patent/AR080172A1/es not_active Application Discontinuation
- 2011-02-15 TW TW100104942A patent/TW201141856A/zh unknown
- 2011-02-16 US US13/028,368 patent/US20120041026A1/en not_active Abandoned
-
2012
- 2012-08-28 ZA ZA2012/06469A patent/ZA201206469B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UY33225A (es) | 2011-09-30 |
| EP2536713A1 (en) | 2012-12-26 |
| AU2011216950A1 (en) | 2012-08-23 |
| JP2013519722A (ja) | 2013-05-30 |
| TW201141856A (en) | 2011-12-01 |
| MX2012008721A (es) | 2012-08-17 |
| CN102762554A (zh) | 2012-10-31 |
| CA2788656A1 (en) | 2011-08-25 |
| AR080172A1 (es) | 2012-03-21 |
| WO2011101774A1 (en) | 2011-08-25 |
| SG183111A1 (en) | 2012-09-27 |
| KR20120123089A (ko) | 2012-11-07 |
| ZA201206469B (en) | 2013-05-29 |
| US20120041026A1 (en) | 2012-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN06631A (fi) | ||
| MX2011010223A (es) | Despliegue de juego de casino que se puede vestir y sistema de rastreo. | |
| HK1139930A1 (en) | Cyclopamine lactam analogs and methods of use thereof | |
| MX2009009428A (es) | Analogos de ciclopamina heterociclicos y metodos de uso de los mismos. | |
| BR112012031620A2 (pt) | atm acessível para deficiente físico | |
| TW200720693A (en) | A comfortable ophthalmic device and methods of its production | |
| SG176656A1 (en) | Microorganisms for the production of 1,4-butanediol and related methods | |
| JO2860B1 (en) | Phenylendazolyl compounds | |
| UA98312C2 (en) | Progesterone receptor antagonists | |
| UA102065C2 (en) | Substituted 4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof | |
| GB201118864D0 (en) | Screen capture | |
| EP3822352A3 (en) | Methods and compositions for modulating apolipoprotein(a) expression | |
| MX2014009657A (es) | Pilar dental para el soporte de protesis dentales y metodo de fabricacion del mismo. | |
| NZ603625A (en) | A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate | |
| AU2011305525A8 (en) | Modulators of the GPR119 receptor and the treatment of disorders related thereto | |
| MY185134A (en) | 6-substituted phenoxychroman carboxylic acis derivatives | |
| MX2012000391A (es) | Composiciones farmaceuticas y formas solidas. | |
| MX2010010345A (es) | Composiciones oftalmicas topicas mejoradas. | |
| AU335070S (en) | Integrated winchhead | |
| MX2012001846A (es) | Metodos y composiciones para el tratamiento de leucemia. | |
| EP2580229A4 (en) | D5 desaturase-defective mutant gene and use thereof | |
| IN2014CN00834A (fi) | ||
| UA103263C2 (ru) | Способ увеличения полового члена и электромеханический экстендер для его реализации | |
| IN2014DN02984A (fi) | ||
| AU326003S (en) | An access floor panel |